Alnylam Announces Closing of Previously Announced Alliance with Genzyme for Discovery, Development, and Commercialization of RNAi Therapeutics as Genetic Medicines

[Business Wire] – Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that the previously announced alliance with Genzyme, a Sanofi company has closed, following the expiration of the Hart-Scott-Rodino waiting period. more

View todays social media effects on ALNY

View the latest stocks trending across Twitter. Click to view dashboard

See who Alnylam is hiring next, click here to view